Dr. Robert S. Bridwell, medical advisor to IBA Molecular North America, Inc., as well as Founder and Chief Medical Officer of PETLinQ LLC is joined by Dr. Lale Kostakoglu, the Director of PET/CT Oncology and Research at Mount Sinai School of Medicine in New York in a Molecular Imaging Panel Discussion at the 2010 SNM Annual Meeting. They discuss the current FDG Positron Emission Tomography (PET) applications for Head and Neck Cancers based on scientific literature and current oncologic guidelines. Areas of focus include the use of FDG PET for staging, restaging and response to therapy. Dr. Bridwell and Dr. Kostakoglu both received reasonable compensation from IBA Molecular North America, Inc. for appearing as part of the panel.
Link to this comment:
All Comments (0)